Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial - Wikidata - wikimedia - TriplyDB

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial

http://www.wikidata.org/entity/Q24630683

about

Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria Artesunate versus quinine for treating severe malaria Artemisinin-resistant malaria: research challenges, opportunities, and public health implications Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium.Artemether for severe malaria Pre-referral rectal artesunate for severe malaria Artesunate versus quinine for treating severe malaria Oral iron supplements for children in malaria-endemic areas Lethal malaria: Marchiafava and Bignami were right Antimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network Investigating the Pathogenesis of Severe Malaria: A Multidisciplinary and Cross-Geographical Approach How patients take malaria treatment: a systematic review of the literature on adherence to antimalarial drugs Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization Designing the next generation of medicines for malaria control and eradication The interplay between drug resistance and fitness in malaria parasites Recent advances in malaria drug discovery Vascular dysfunction as a target for adjuvant therapy in cerebral malaria Malaria in South America: a drug discovery perspective Age, Spatial, and Temporal Variations in Hospital Admissions with Malaria in Kilifi County, Kenya: A 25-Year Longitudinal Observational Study Perivascular Arrest of CD8+ T Cells Is a Signature of Experimental Cerebral Malaria Plasmodium Infection Is Associated with Impaired Hepatic Dimethylarginine Dimethylaminohydrolase Activity and Disruption of Nitric Oxide Synthase Inhibitor/Substrate Homeostasis Pathophysiological Mechanisms in Gaseous Therapies for Severe Malaria Antiparasitic therapy New developments in anti-malarial target candidate and product profiles The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites Diagnosing severe falciparum malaria in parasitaemic African children: a prospective evaluation of plasma PfHRP2 measurement Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar A randomized pilot study of L-arginine infusion in severe falciparum malaria: preliminary safety, efficacy and pharmacokinetics Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria Dihydroartemisinin-piperaquine vs. artemether-lumefantrine for first-line treatment of uncomplicated malaria in African children: a cost-effectiveness analysis Anticancer properties of distinct antimalarial drug classes Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial Characteristics of admissions and variations in the use of basic investigations, treatments and outcomes in Kenyan hospitals within a new Clinical Information Network Perceived Benefits, Harms, and Views About How to Share Data Responsibly: A Qualitative Study of Experiences With and Attitudes Toward Data Sharing Among Research Staff and Community Representatives in Thailand Decreasing incidence of severe malaria and community-acquired bacteraemia among hospitalized children in Muheza, north-eastern Tanzania, 2006-2010 Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria Pre-referral Rectal Artesunate Treatment by Community-Based Treatment Providers in Ghana, Guinea-Bissau, Tanzania, and Uganda (Study 18): A Cluster-Randomized Trial.Malaria in Uganda: challenges to control on the long road to elimination: I. Epidemiology and current control efforts.

P2860

Q17485067-17CF8271-001F-4944-B582-21A32B0A5FB6 Q21032520-F6702A5A-E6C0-4ED8-BE57-4DCBCFCDC17F Q21032532-BA442D62-0A6C-4E36-A603-4594D19FD769 Q21034066-914C63BC-E6EC-45F9-B243-ADE3CB5CD15E Q24193663-DBC75D03-044C-4BD1-AD91-C1257A96E7F4 Q24194527-892D994C-1C50-42EC-854F-BB6E588B02D9 Q24235937-7807F904-F21A-44C4-928D-9E6D12C89973 Q24235999-3692B8A3-1A0B-433E-9EE2-B34DA7A3EAD1 Q24611213-F6A41C8A-45F0-46A3-A7D3-C992E2156784 Q26799713-B28DD973-5052-4441-810F-7008C4C9A2FF Q26799717-40C9F6E5-6CCE-4F62-BC03-40A942244C3A Q26823483-935E7271-AC27-4611-AD50-0D92C50A2FC6 Q26830528-6B1639CE-7A97-4399-870A-DC4430D7288D Q26859195-B80FA8DF-7433-4CC1-89C0-02D412CD3651 Q26998596-A730042E-4A6E-491C-9CD5-9DD8DBE3BA91 Q27010534-59C97AA1-9D24-45CE-8304-A5ECD7DAF7DA Q27025436-AFD6E34A-EB8B-4785-A6F4-969BD3500A0C Q27026447-FC822E59-2A0A-495F-A687-37DC3F39790D Q27306991-28579CAE-6FFF-4543-B821-70295F06FE47 Q27316972-000DB651-10C0-49B9-AB81-B03426C04C19 Q27317763-5F655C1B-1CD0-46BB-8056-05441D413829 Q28080030-37D4DC23-4191-4BF9-9C94-7E7B3FED32C1 Q28239164-9530A6EB-2285-400E-9E93-EEE35EF6C88D Q28468598-96E9E65F-AF46-4F0D-A8B7-F03FA1D7BBF4 Q28480979-14D27446-2175-4159-91D7-4CF290A3B488 Q28482447-62141CED-76D8-4701-8EDD-CD04AAE4CE48 Q28486022-95F2B6D6-5B3C-494A-B097-D702451E1DC6 Q28487636-8C420114-3A26-48A8-9CF5-8A36C196EB12 Q28487881-9C0C68B7-0C67-40DE-8FFB-573B4B15D6DB Q28534942-674A6367-69F6-46E8-AFAB-C154173FA81B Q28535601-E6C723FE-10A9-482C-92FF-C9DD575C4395 Q28538065-F73DC3A6-2809-4816-BA62-FD46763B52DE Q28538116-294DA8CD-08A6-49F8-A8C8-21BAE6AC7FAD Q28552379-F67219D6-DEAF-4F45-BAD8-F0C28CABCDFC Q28602728-65B9A802-5C88-4AE5-98C3-031AF7AB2873 Q28608554-746E03AD-0FDC-4986-B2D3-07908FDC9FE5 Q28742561-DA03E6DF-05E8-42B3-8A0B-C5D44260890C Q28742640-4CD00E99-FF95-4360-96FE-3100B150F22A Q30151536-47381DBE-E38D-499A-9997-5CB236E59E59 Q30226671-A00471A4-0CE0-4028-8361-A16FE1BBCED6

P2860

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial

http://www.wikidata.org/entity/Q24630683

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Artesunate versus quinine in t ...... n open-label, randomised trial

@ast

Artesunate versus quinine in t ...... n open-label, randomised trial

@en

Artesunate versus quinine in t ...... n open-label, randomised trial

@nl

type

label

Artesunate versus quinine in t ...... n open-label, randomised trial

@ast

Artesunate versus quinine in t ...... n open-label, randomised trial

@en

Artesunate versus quinine in t ...... n open-label, randomised trial

@nl

prefLabel

Artesunate versus quinine in t ...... n open-label, randomised trial

@ast

Artesunate versus quinine in t ...... n open-label, randomised trial

@en

Artesunate versus quinine in t ...... n open-label, randomised trial

@nl

P1433

Q24630683-DAF758FC-55AC-427F-A59F-B1C06A1968A4

P1476

Q24630683-175C2115-C4B5-4215-BB6D-E3E24E6771D2

P2093

Q24630683-0B3CB56C-C11D-4F20-B3BA-9D1F162A8C8B

Q24630683-0D48F384-BBA3-4D43-BC72-80DB9BCEBD8F

Q24630683-103E374E-BD2F-4041-8034-9F44CB6908D5

Q24630683-1465BE30-A616-4CE1-BBB6-9C60926A97AB

Q24630683-162F1E5C-6A83-4443-A6EC-E0E329F4EDD8

Q24630683-18291436-8426-48B5-8B76-62E3E438E28C

Q24630683-22526B5A-8D0B-4209-A932-AF4F5B1F7A01

Q24630683-264173C2-60D4-4681-A9CB-3F4F3CED9E0E

Q24630683-29E6FB9E-EC9D-4C37-B966-20616DBD0B40

Q24630683-3687972C-9404-46C7-864C-D5EF665B2402

P2860

Q24630683-0513EB6B-DC5F-4238-98C4-9758C72DBBCA

Q24630683-05FFE628-4D71-4C86-BB1C-C7591E6F9544

Q24630683-0C28BC64-4EA5-4D29-AC6C-AEA00E7F979F

Q24630683-1A1DC62A-E576-4FD6-907A-9F08E8F4471A

Q24630683-23D0E8E2-09E3-435E-9BF6-0C9C483E29EA

Q24630683-2EE7758A-F387-44E7-BDD6-F64F261984DB

Q24630683-384A74CB-2371-41D4-98F9-63F8DC5A9281

Q24630683-3B28F184-3FFC-41CE-8CE0-CD7A67A23A19

Q24630683-55DEC533-0795-48D6-A4AF-10BB5E090377

Q24630683-57568015-5924-4027-8B96-5C30D04E6594

P304

Q24630683-F9B6033E-27CB-4867-B894-BA057DCAB2FB

P31

Q24630683-4D22C22F-0F31-4FE2-8572-8CB18B60DD76

P3181

Q24630683-CE3D0AD5-655B-417C-9709-CE7A10F1910A

P356

Q24630683-0708FAC2-8C15-4984-B5F0-C590F5F01A4C

P407

Q24630683-F4CFCAA9-E2DE-4AE4-A0DD-21CDFCCCB041

P433

Q24630683-37732055-E668-4717-B9DC-4CF353741FCB

P478

Q24630683-CFDBF79E-FE83-4046-B139-FBD0540C16D6

P50

Q24630683-055EA2CF-3A99-472E-938F-8542677C21A6

Q24630683-2633EFB7-CFC6-416F-AD01-3B8937B72B87

Q24630683-41250F06-26A1-4016-9329-38A1602CEB1C

Q24630683-4EFF0332-19BB-41B2-A086-A8CA88DF1870

Q24630683-8889649D-BF7B-4720-865D-00FF18CFDE1C

Q24630683-91877C81-13B9-4BC6-AD5F-9AFAF555B8ED

Q24630683-A8A828A1-10B3-400E-9596-EC8FB62A4643

Q24630683-A8FC1A0F-8C59-4455-93F9-B223264E741F

Q24630683-BA804D3E-6620-4E13-8E20-62B0D6397E79

Q24630683-E0083FA1-CA13-4191-A97B-B469E7101B9A

P577

Q24630683-C56C8B47-5B4E-4A0E-8AC7-17DF78CF39CA

P698

Q24630683-5E9C78D2-1D21-4A02-B8B0-7C0A775AF1BF

P921

Q24630683-49A7EE7C-6248-45C2-9FD2-D715416A7778

Q24630683-52A76032-9601-43EF-8D33-F882BFB46E5C

Q24630683-FC6521B0-2BB5-4231-B926-1F429DFDEAD6

P932

Q24630683-AC7F2DEB-A862-4E81-8493-A8A0E7459176

P3181

P356

S0140-6736(10)61924-1

P1433

P1476

Artesunate versus quinine in t ...... n open-label, randomised trial

@en

P2093

Aline Uwimana

http://www.w3.org/2001/XMLSchema#string

Amir Seni

http://www.w3.org/2001/XMLSchema#string

Antoinette K Tshefu

http://www.w3.org/2001/XMLSchema#string

Catherine Kahabuka

http://www.w3.org/2001/XMLSchema#string

Charles J Woodrow

http://www.w3.org/2001/XMLSchema#string

Delia Bethell

http://www.w3.org/2001/XMLSchema#string

Ermelinda Gomes

http://www.w3.org/2001/XMLSchema#string

Esther Kivaya

http://www.w3.org/2001/XMLSchema#string

George Mtove

http://www.w3.org/2001/XMLSchema#string

Ilse C E Hendriksen

http://www.w3.org/2001/XMLSchema#string

P2860

Global, regional, and national causes of child mortality in 2008: a systematic analysis

A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria.

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.

Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria.

Combined intravenous treatment with artesunate and quinine for severe malaria in Italy

Artemether bioavailability after oral or intramuscular administration in uncomplicated falciparum malaria

Intramuscular bioavailability and clinical efficacy of artesunate in gabonese children with severe malaria.

UK malaria treatment guidelines.

In vivo parasitological measures of artemisinin susceptibility

The pharmacokinetic properties of intramuscular artesunate and rectal dihydroartemisinin in uncomplicated falciparum malaria

P304

1647-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

285144

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/S0140-6736(10)61924-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

9753

http://www.w3.org/2001/XMLSchema#string

P478

376

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas John White

Nicholas P J Day

Kasia Stepniewska

Kathryn Maitland

Kalifa A Bojang

Samuel Blay Nguah

P577

2010-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21062666

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum

P932

3033534

http://www.w3.org/2001/XMLSchema#string